Inflammatory Myopathies Flashcards
antibodies of T1DM
• ICA positive • Anti-GAD
positive • ICA 512 positive
T2DM TESTING
Waist circumference >80 cm (females) and >90 cm
(males), or Waist-hip ratio (WHR) of >1 for males
and >0.85 for females
T
A 75-gram OGTT is preferred as the rst test in the following individuals who have: (Grade B, Level 3)
- A previous FBS showing Impaired Fasting Glucose (100 to 125 mg/dL or 5.6 to 6.9 mmol/L)
- Previous diagnosis of Cardiovascular Disease (Coronary Artery Disease, Stroke, Peripheral Arteriovascular Disease) or who are at high risk for cardiovascular disease.
- A diagnosis of Metabolic Syndrome
The criteria for pre-diabetes is:
• Impaired Fasting Glucose de ned as FBS of 5.6
mmol/L (100 mg/dL) up to 125 mg/dL or 6.9 mmol/L (Grade B, Level 2)
Impaired Glucose Tolerance: casual blood glucose of 7.7 up to 11.0 mmol/L (140-199 mg/dL) OR 2-hr blood sugar in the 75-gm OGTT equal to 7.7 (140 mg/dL) up to 11.0 mmol/L (199 mg/dL) (Grade B, Level 2)
Normal blood is sugar is de ned as:
• An FBS <5.6 mmol/L (100 mg/dL), or
• Random/casual blood glucose <7.7 (140 mg/dL),
or
• 2-hr blood sugar in the 75-gm OGTT <7.7 (140
mg/dL) (Grade B, Level 2)
Testing should be considered in all adults >40 yo
• Consider earlier testing if with at least one other risk
factor as follows:
History of IGT or IFG
o History of GDM or delivery of a baby weighing 8 lbs
or above
o Polycystic ovary syndrome (PCOS)
o Overweight: Body Mass Index (BMI)2 of >23 kg/m2
or Obese: BMI of >25 kg/m2, or
o Waist circumference >80 cm (females) and >90 cm
(males), or Waist-hip ratio (WHR) of >1 for males
and >0.85 for females
o First degree relative with Type 2 diabetes
o Sedentary lifestyle
o Hypertension (BP >140/90 mm Hg)
oDiagnosisorhistoryofanyvasculardiseasesinclud-
ing stroke, peripheral arterial occlusive disease,
coronary artery disease
o Acanthosis nigricans
o Schizophrenia
o Serum HDL <35 mg/dL (0.9 mmol/L) and/or
o Serum Triglycerides >250 mg/dL (2.82 mmol/L)
Routine testing for gestational diabetes is recommended at 24 to 28 weeks age of gestation for women with no risk factors
TRUE
Which tests should be used to screen pregnant women for gestational diabetes?
An oral glucose tolerance test (OGTT), preferably the 75-g OGTT, should be used to screen for gestational diabetes
What criteria will be used to interpret the 75-g OGTT?
FBS 92
1-hour 180
2-hour 153
3-hour NA
glucosuria
defined as trace glucose of
75 to >250 mg/dL
How should we follow up women who develop diabetes during pregnancy?
A 75-gram oral glucose tolerance test should be done 6–12 weeks after delivery in GDM women who do not have diabetes immediately postpartum.
After GDM, _____ of women develop type 2 diabetes within 10 years
35–60%
Post partum data indicates that only 34% of the women with IGT or type 2 diabetes had impaired fasting glucose and that 44% of those with type 2 diabetes had fasting levels <100 mg/day (<5.5 mmol/l).
TRUE
Without such data, it is recommended that after initial postpartum testing, an oral glucose tolerance test should be repeated in 1 year and, at a minimum, every 3 years thereafter.
TRUE
The CANDI- Manila showed that as much as ____ of newly diagnosed Filipino diabetics has proteinuria by routine urinalysis.
42%
Candidates for screening with stress testing are patients with a history of peripheral or carotid arterial disease and those over age 35 who have a sedentary lifestyle and are planning to begin a vigorous exercise program (Grade C, Level 3).
TRUE
In the UKPDS, microvascular endpoints (including retinopathy and nephropathy) decreased by 37% with each 1% absolute reduction in HbA1c, with no threshold observed
true
pre-meal self-monitoring levels remain well controlled (<7.0 mmol/litre or 126 mg/dL)
t
In order to achieve A1C of 7.0%, people with diabetes should aim for2:
o An FPG or preprandial PG target of 4.0 to 7.0
mmol/L (72 to 126 mg/dl) [Grade B, Level 21, for type 1; Grade B, Level 22,3, for type 2 diabetes]; and
o A 2-hour postprandial PG target of 5.0 to 10.0 mmol/L (90 to 180 mg/dL) [Grade B, Level 21, for type 1 diabetes; Grade B, Level 22,3, for type 2 diabetes].
• Alternatively,capilarybloodglucosetargetscanbe: FBS 90-130 mg/dL (ADA), PPBG <180 (ADA)
t
Conditions that de ne complicated UTI
Presenceofanindwellingurinarycatheterorintermittentcatheterization
• Incomplete emptying of the bladder with >100 ml retained urine post-
voiding
• Impaired voiding due to neurogenic bladder, cystocoele
• Obstructive uropathy due to bladder outlet obstruction, calculus,
urethral or ureteric strictures, tumors
• Vesicoureteral re ux & other urologic abnormalities including surgically
created abnormalities
• Chemical or radiation injuries of the uroepithelium
• Peri- or post-operative UTI
• Azotemia due to intrinsic renal disease
• Renal transplantation
• Diabetes mellitus
• Immunosuppressive conditions – e.g. febrile neutropenia, HIV-AIDS
• UTI caused by unusual pathogens (M. tuberculosis, Candida spp.)
• UTI caused by multi-drug resistant organisms (MDROs)
• UTI in males except in young males presenting exclusively with lower
UTI symptoms
• Urosepsis